Combination Studies with the Vascular Disrupting Agent Ca4p: Clinical Studies Combined with Chemotherapy and Radioimmunotherapy, and Dce-mri and Immunohistochemistry Correlation - Andrew Gaya - Books - LAP LAMBERT Academic Publishing - 9783838343532 - May 10, 2011
In case cover and title do not match, the title is correct

Andrew Gaya
Combination Studies with the Vascular Disrupting Agent Ca4p: Clinical Studies Combined with Chemotherapy and Radioimmunotherapy, and Dce-mri and Immunohistochemistry Correlation

Get an email once the item is available
Do you have a profile? Log in
Get notified about new Andrew Gaya releases

Our customers say:

14-day return policy in accordance with European consumer protection law
Top ranking on Trustpilot
Add to your iMusic wish list

Not rated yet

This work represents studies carried out at Mount Vernon Hospital and UCL, and sponsored by Cancer Research UK, between 2003 and 2006. Phase I/II Clinical trial studies of the vascular disrupting agent Combretastatin A4 Phosphate (CA4P) are presented - in combination with cytotoxic chemotherapy (Paclitaxel and Carboplatin), and radioimmunotherapy. Dynamic Contrast Enhanced MRI data from the studies is presented and discussed, and a supporting immunohistochemistry correlation study of vascular markers is also presented.

Media Books     Paperback Book   (Book with soft cover and glued back)
Released May 10, 2011
ISBN13 9783838343532
Publishers LAP LAMBERT Academic Publishing
Pages 256
Dimensions 150 × 15 × 226 mm   ·   399 g
Language German  

See all of Andrew Gaya ( e.g. Paperback Book )